CW069 | CAS#1594094-64-0 | HSET inhibitor

MedKoo Cat#: 406974 | Name: CW069

Description:

WARNING: This product is for research use only, not for human or veterinary use.

CW069 is an allosteric inhibitor of HSET. CW069 showed marked activity against HSET in vitro. The inhibitor induced multipolar mitoses only in cells containing supernumerary centrosomes. CW069 therefore constitutes a valuable tool for probing HSET function and, by reducing the growth of cells containing supernumerary centrosomes, paves the way for new cancer therapeutics.

Chemical Structure

CW069

CAS#1594094-64-0

Theoretical Analysis

MedKoo Cat#: 406974

Name: CW069

CAS#: 1594094-64-0

Chemical Formula: C23H21IN2O3

Exact Mass: 500.0597

Molecular Weight: 500.34

Elemental Analysis: C, 55.21; H, 4.23; I, 25.36; N, 5.60; O, 9.59

Price and Availability

Size	Price	Availability
10mg	USD 150.00	Ready to ship
25mg	USD 250.00	Ready to ship
50mg	USD 450.00	Ready to ship
100mg	USD 750.00	Ready to ship
200mg	USD 1,350.00	Ready to ship
500mg	USD 2,650.00	Ready to ship
1g	USD 3,650.00	Ready to ship

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

CW069; CW-069; CW 069.

IUPAC/Chemical Name

5-Iodo-2-[[(2S)-1-oxo-3-phenyl-2-[(phenylmethyl)amino]propyl]amino]-benzoic acid

InChi Key

IRDIXDXDSUBHIU-NRFANRHFSA-N

InChi Code

InChI=1S/C23H21IN2O3/c24-18-11-12-20(19(14-18)23(28)29)26-22(27)21(13-16-7-3-1-4-8-16)25-15-17-9-5-2-6-10-17/h1-12,14,21,25H,13,15H2,(H,26,27)(H,28,29)/t21-/m0/s1

SMILES Code

O=C(O)C1=CC(I)=CC=C1NC([C@@H](NCC2=CC=CC=C2)CC3=CC=CC=C3)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Product Data

Product Data

Certificate of Analysis

View CoA: current batch, Lot#XPR70418

QC Data

View QC data: current batch, Lot#XPR70418

Safety Data Sheet (SDS)

View Safety Data Sheet (SDS)

Instruction

View handling instruction

Biological target:

CW-069 is an allosteric inhibitor of microtubule motor protein HSET with an IC50 of 75 μM.

In vitro activity:

Using IF, this study next examined the mitotic phenotypes induced by CW069 in N1E-115 and NHDF cells, with a strong focus on centrosome numbers and mitotic spindle morphology. Antibodies against α-tubulin, CDK5RAP2, and DAPI were employed to visualize MTs, centrosomes, and DNA, respectively. It was hypothesized that small-molecule inhibition of HSET would give rise to mitotic spindle defects similar to those reported after HSET knockdown by siRNA transfection, and this was indeed the case. Upon treatment with CW069, a significant increase in multipolar spindle formation was observed in N1E-115 cells (control 30%, 100 μM 98%, 200 μM 86%, p < 0.001; Figure 4A), but not in NHDF cells (Figure 4B). After treatment, the N1E-115 cells formed multipolar spindles due to a lack of centrosome clustering, consistent with HSET inhibition in cells with supernumerary centrosomes (Figure 4C). The mitotic spindle morphology of treated NHDF cells was unchanged compared with control (Figure 4G). Reference: Chem Biol. 2013 Nov 21;20(11):1399-410. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898838/

In vivo activity:

TBD

	Solvent	mg/mL	mM
Solubility
	DMSO	60.7	121.26
	DMSO:PBS (pH 7.2) (1:1)	0.5	1.00
	DMF	30.0	59.96
	Ethanol	3.3	6.50

Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 500.34 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:

1. Watts CA, Richards FM, Bender A, Bond PJ, Korb O, Kern O, Riddick M, Owen P, Myers RM, Raff J, Gergely F, Jodrell DI, Ley SV. Design, synthesis, and biological evaluation of an allosteric inhibitor of HSET that targets cancer cells with supernumerary centrosomes. Chem Biol. 2013 Nov 21;20(11):1399-410. doi: 10.1016/j.chembiol.2013.09.012. Epub 2013 Oct 24. PMID: 24210220; PMCID: PMC3898838.

In vitro protocol:

In vivo protocol:

TBD

1: Watts CA, Richards FM, Bender A, Bond PJ, Korb O, Kern O, Riddick M, Owen P, Myers RM, Raff J, Gergely F, Jodrell DI, Ley SV. Design, synthesis, and biological evaluation of an allosteric inhibitor of HSET that targets cancer cells with supernumerary centrosomes. Chem Biol. 2013 Nov 21;20(11):1399-410. doi: 10.1016/j.chembiol.2013.09.012. PubMed PMID: 24210220; PubMed Central PMCID: PMC3898838. 2: Bhakta-Guha D, Saeed ME, Greten HJ, Efferth T. Dis-organizing centrosomal clusters: specific cancer therapy for a generic spread? Curr Med Chem. 2015;22(6):685-94. Review. PubMed PMID: 25515519.